Delivery Order SPE2DP20D0002-SPE2DP25F4432
Award Date
3/6/25
Potential Completion Date
3/25/25
Potential Value
$495K
Federal Agency
Medical Supply Chain
Awardee
Teva Pharmaceuticals Usa, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Parsippany, NJ 07054, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The $317,609.46 firm fixed-price delivery order is for the supply of Adenovirus Type 4 vaccines, supporting military immunization programs. Teva Pharmaceuticals USA, Inc. is a subsidiary of the global Teva Pharmaceutical Industries Ltd. and has numerous prime contract awards with federal agencies, including...
The U.S. government agency Defense Logistics Agency (DLA) Troop Support Medical awarded a $158,804.73 firm-fixed-price delivery order contract to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, for the supply of Adenovirus Type 4 vaccine. This delivery order is part of a larger contract vehicle, and Teva has received multiple prior delivery orders for this vaccine to support military immunization programs. Teva also holds several significant Indefinite...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract, valued at $165,156.93, is for the delivery of Adenovirus Type 4 vaccines, which support military immunization programs. Teva Pharmaceuticals USA, Inc. has received numerous federal contract awards from the DLA for the supply of critical pharmaceutical products, including...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract, valued at $165,156.93, is for the delivery of Adenovirus Type 4 vaccine, which supports military immunization programs. The contract is a firm-fixed-price delivery order with a performance period through March 25, 2025. Teva Pharmaceuticals USA, Inc. is the prime contractor, and there are no...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract, valued at $635,218.92, is for the delivery of Adenovirus Type 4 vaccine, which supports military immunization programs. This award is not a set-aside and Teva, as a large business, competed without any small business designations. Teva is a major supplier of critical...
This is a delivery order awarded by the Medical Supply Chain of the Defense Logistics Agency (DLA) to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The $476,414.19 firm-fixed-price contract is for the supply of Adenovirus Type 4 vaccine, which is used in military immunization programs. The contract has an ultimate completion date of April 30, 2024. Teva Pharmaceuticals USA, Inc. is an experienced federal contractor, holding several indefinite-delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned pharmaceutical manufacturer. The contract is for the delivery of Adenovirus Type 4 vaccine, which supports military immunization programs. The firm-fixed-price delivery order has a ceiling value of $660,627.72 and a period of performance through March 25, 2025. This award is not set-aside and represents one of Teva's many unrestricted contract awards...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract, valued at $330,313.86, is for the delivery of Adenovirus Type 4 vaccine, which supports military immunization programs. This award is not set aside and Teva competes as a large business. Teva Pharmaceuticals USA, Inc. has received numerous federal contract awards from the...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, for the supply of Adenovirus Type 4 vaccine. The contract has a ceiling value of $165,156.93 and a period of performance through March 25, 2025. Teva is a major pharmaceutical supplier to federal agencies, providing critical medical products including vaccines, antiviral medications, respiratory...
This federal contract award, valued at $990,941.58, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract is a delivery order for the supply of Adenovirus Type 4 vaccine, a critical medical product that supports military immunization programs. The contract is a firm-fixed-price arrangement with a period of performance through March 25, 2025. Teva Pharmaceuticals USA, Inc....